Myocardial Infarction Cardiac Patch
Myocardial Infarction
PreclinicalActive
Key Facts
About Matricelf
Autologous iPSC‑based tissue implants for curative spinal cord injury and broader regenerative medicine.
View full company profileTherapeutic Areas
Other Myocardial Infarction Drugs
| Drug | Company | Phase |
|---|---|---|
| KEAP1/NRF2 Program | Grove Biopharma | Pre-clinical |
| VANADIS® BMOV | CFM Pharma | Phase 1 |
| QuickProfile Cardiac Markers | LumiQuick Diagnostics | Commercial |
| Lead Peptide Program | ResoTher Pharma | Phase 2a |